The influence of vascular risk factors on cognitive decline in patients with dementia: A systematic review

Maturitas

Volumn 76, Issue 2, 2013, Pages 113-117

  Blom, Kim ^a   Emmelot Vonk, Mariëlle H ^a   Koek, Huiberdina L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alzheimer Disease; Dementia; Diabetes mellitus; Hypercholesterolemia; Hypertension; Vascular risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; COCHRANE LIBRARY; COGNITIVE DEFECT; COHORT ANALYSIS; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DSM-IV; EMBASE; FRAMINGHAM RISK SCORE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEDLINE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; OBESITY; PSYCINFO; REVIEW; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

ALZHEIMER DISEASE; DEMENTIA; DIABETES MELLITUS; HYPERCHOLESTEROLEMIA; HYPERTENSION; VASCULAR RISK FACTORS;

AGED; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84888639541     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2013.06.011     Document Type: Review

References (32)

1. , Available from: http://www.alz.co.uk/research/statistics [accessed 07.11.12] Dementia statistics 2011; 2011.
2. Etters L, Goodall D, Harrison BE. Caregiver burden among dementia patient caregivers: A review of the literature. Journal of the American Academy of Nurse Practitioners 2008;20(August (8)):423-8.
3. , Available from: http://www.alzheimer-nederland.nl/media/38133/ factsheet% 20dementie%20algemeen%20-%20publieksversie%20-%2016%20feb%202012. pdf [accessed 07.11.12] Cijfers en feiten over dementie. 2012; 2012.
4. Skoog I, Lernfelt B, Landahl S, et al. A 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347(April (9009)): 1141-5.
5. Gamba P, Testa G, Sottero B, Gargiulo S, Poli G, Leonarduzzi G. The link between altered cholesterol metabolism and Alzheimer?s disease. Annals of the New York Academy of Sciences 2012;1259(July (1)): 54-64.
6. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA. Statins and the risk of dementia. Lancet 2000;356(November (9242)): 1627-31.
7. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: A systematic review. Lancet Neurology 2006;5(January (1)):64-74.
8. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. Journal of the American College of Cardiology 2004;43(May (10)):1731-7.
9. Anstey KJ, von Sanden C, Salim A, O?Kearney R. Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. American Journal of Epidemiology 2007;166(August (4)): 367-78.
10. Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Latelife body mass index and dementia incidence: nine-year follow-up data from the kungsholmen project. Journal of the American Geriatrics Society 2008 Jan;56(1):111-6.
11. Bellew KM, Pigeon JG, Stang PE, Fleischman W, Gardner RM, Baker WW. Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer?s type. Alzheimer Disease and Associated Disorders 2004;18(October-December (4)):208-13.
12. Chaves ML, Camozzato AL, Kohler C, Kaye J. Predictors of the progression of dementia severity in brazilian patients with Alzheimer?s disease and vascular dementia. International Journal of Alzheimer?s Disease 2010;(March), 2010:673581.
13. Musicco M, Palmer K, Salamone G, et al. Predictors of progression of cognitive decline in Alzheimer?s disease: The role of vascular and sociodemographic factors. Journal of Neurology 2009;256(August (8)):1288-95.
14. Sakurai H, Hanyu H, Sato T, et al. Vascular risk factors and progression in Alzheimer?s disease. Geriatrics & Gerontology International 2011;11(April (2)):211-4.
15. Bhargava D, Weiner MF, Hynan LS, Diaz-Arrastia R, Lipton AM. Vascular disease and risk factors, rate of progression, and survival in Alzheimer?s disease. Journal of Geriatric Psychiatry and Neurology 2006;19(June (2)):78-82.
16. Helzner EP, Luchsinger JA, Scarmeas N, et al. Contribution of vascular risk factors to the progression in Alzheimer?s disease. Archives of Neurology 2009;66(March (3)):343-8.
17. Li J, Zhang M, Xu ZQ, et al. Vascular risk aggravates the progression of Alzheimer?s disease in a chinese cohort. Journal of Alzheimer?s Disease 2010;20(2):491-500.
18. van Kan GA, Rolland Y, Nourhashemi F, Coley N, Andrieu S, Vellas B, REAL.FR group. Cardiovascular disease risk factors and progression of Alzheimer?s disease. Dementia and Geriatric Cognitive Disorders 2009;27(February (3)):240-6.
19. Mielke MM, Rosenberg PB, Tschanz J, et al. Vascular factors predict rate of progression in Alzheimer?s disease. Neurology 2007;69(November (19)):1850-8.
20. van Bruchem-Visser RL, Mattace-Raso FU, van der Cammen TJ. High systolic and pulse pressure levels are associated with better cognitive performance in patients with probable Alzheimer?s disease: A cross-sectional observational study in a geriatric outpatient population. Dementia and Geriatric Cognitive Disorders 2009;28(4):320-4.
21. Razay G, Williams J, King E, Smith AD, Wilcock G. Blood pressure, dementia and Alzheimer?s disease: The OPTIMA longitudinal study. Dementia and Geriatric Cognitive Disorders 2009;28(1):70-4.
22. Ciobica A, Padurariu M, Bild W, Stefanescu C. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer?s disease. Psychiatria Danubina 2011;23(December (4)):340-6.
23. Li L, Cao D, Desmond R, et al. Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer?s disease. Dementia and Geriatric Cognitive Disorders 2008;26(October (4)):384-90.
24. Dominguez RO, Marschoff ER, Gonzalez SE, Repetto MG, Serra JA. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer?s disease patients. Diabetes Research and Clinical Practice 2012;98(October (1)):68-74.
25. RavonaSpringer R, Luo X, Schmeidler J, et al. Diabetes is associated with increased rate of cognitive decline in questionably demented elderly. Dementia and Geriatric Cognitive Disorders 2010;29(February (1)):68-74.
26. Sanz C, Andrieu S, Sinclair A, Hanaire H, Vellas B, REAL.FR Study Group. Diabetes is associated with a slower rate of cognitive decline in Alzheimer?s disease. Neurology 2009;73(October (17)):1359-66.
27. Regan C, Katona C, Walker Z, Hooper J, Donovan J, Livingston G. Relationship of vascular risk to the progression of Alzheimer?s disease. Neurology 2006;67(October (8)):1357-62.
28. Coin A, Veronese N, De Rui M, et al. Nutritional predictors of cognitive impairment severity in demented elderly patients: The key role of BMI. Journal of Nutrition, Health & Aging 2012;16(6):553-6.
29. Kume K, Hanyu H, Sato T, et al. Vascular risk factors are associated with faster decline of Alzheimer?s disease: A longitudinal SPECT study. Journal of Neurology 2011;258(July (7)):1295-303.
30. Roselli F, Tartaglione B, Federico F, Lepore V, Defazio G, Livrea P. Rate of MMSE score change in Alzheimer?s disease: influence of education and vascular risk factors. Clinical Neurology and Neurosurgery 2009;111(May (4)):327-30.
31. Petrovska S, Dejanova B, Jurisic V. Estrogens: mechanisms of neuroprotective effects. Journal of Physiology and Biochemistry 2012;68(February):455-60.
32. Nelson LR, Bulun SE. Estrogen production and action. Journal of the American Academy of Dermatology 2001;45(September):S116-24.